Best Neoplasm Podcasts (2024)

1
257. Superfluous Production- Approach to Myeloproliferative Neoplasm's 16:01

2h ago16:01

16:01

Send us a text Let's talk about the BCR:ABL negative MPNs! Written by Dr. Sarah Ge (Internal Medicine Resident), reviewed by Dr. Christopher Hillis @HemeHillis (Hematology) and Dr. John Neary @jddneary (General Internal Medicine). Infographic by Dr. Caitlyn Vlasschaert @DrFlashHeart (Internal Medicine Resident). Support the show…

1
256. Snowmageddon - An approach to Leukostasis 11:28

1d ago11:28

11:28

Send us a text Written by: Dr. Roslyn Mainlaind (Internal Medicine Resident) Reviewed by: Dr. Lindsay Anderson (General Internist) & Dr. Karine Gauthier (Hematologist) Support the showBy Medicine Pods: The Intern at Work

1
Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma 20:41

11d ago20:41

20:41

Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD. Related Content: Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

1
255. CSIM- Top Papers of the Year 2024 Live Episode 55:16

7d ago55:16

55:16

Send us a text Take a listen to our live recording of The Canadian Conference of Internal Medicine Top papers of the year 2024 session! We talk about recent studies involving alzheimer's dementia, community acquired pneumonia, atrial fibrillation, MASLD and long covid. Host: Dr. Zahra Merali, Expert: Dr. Rajender Hanmiah. Check out www.medicinepods…

1
Relapsed/Refractory Multiple Myeloma: Role and Safety of Bispecific Antibodies 20:40

10d ago20:40

20:40

In this episode, Caitlin Costello, MD, discusses important topics related to relapsed/refractory (R/R) multiple myeloma (MM), including: 3 bispecific antibodies approved for the treatment of R/R MM that target BCMA or GPRC5D The role of bispecific antibodies in R/R MM Safety considerations for patients while receiving a bispecific antibody Emerging…

1
Episode 38 - NEN Treatments: Focus on Liver-Directed Therapies (Part I: Overview and Ablative Techniques Including Histotripsy) 31:31

14d ago31:31

31:31

ABOUT THIS EPISODE In this 2-part series, Dr. Osman Ahmed from University of Chicago covers liver-directed therapies for neuroendocrine neoplasms (NENs or neuroendocrine cancer). In this first episode, he outlines the types of liver-directed therapies and elaborates on ablative techniques including the newest technique, histotripsy. Listen to a fra…

1
254. Months of Monocytosis – An approach to CMML 17:17

10d ago17:17

17:17

Send us a text In this episode, we discuss the clinical presentation, work-up, and treatment of CMML. Our medicine minute discusses emerging evidence on the use of ruxolitinib for CMML treatment. Written by: Dr. Elliot Smith (Internal Medicine Resident) Reviewed by: Dr. Stephanie Lee (Hematology and Oncology) and Dr. Christophe Langois (General Int…

1
Gastroenteropancreatic Neuroendocrine Tumors: Diagnosis, Findings, and Recommendations 28:28

14d ago28:28

28:28

In this episode, Thor R. Halfdanarson, MD, and Jonathan Strosberg, MD, discuss important topics related to gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including: The diagnosis and typical presenting symptoms of GEP-NETs Findings from recent key phase III studies including NETTER-2 and CABINET Recommendations for treatment sequencing No…

1
253. CSIM Special Episode- Internists can Help the Planet, Part 2 42:56

17d ago42:56

42:56

Send us a text Up to 30% of all healthcare offers no clinical value to patients. Reducing this care has the co-benefit of decreasing healthcare's carbon footprint. In this special CSIM episode, host Dr. Zahra Merali sits down with guests Dr. Billy Silverstein @WKSilverstein (General Internist, University of Toronto) and Dr. Owen Luo @OwenLuo5 (Inte…

1
Enhancing Risk Stratification for Pediatric B-Cell Acute Lymphoblastic Leukemia: No Longer a ‘PI’ in the Sky Idea? 18:11

22d ago18:11

18:11

In this episode, Contributing Editor Lauren Pommert, MD, a pediatric oncologist specializing in children with leukemia at Cincinnati’s Children in Cincinnati, Ohio, talks with Natalie DelRocco, PhD, a senior statistician for the Children’s Oncology Group’s Bone Tumors Committee and an assistant professor of clinical population and public health sci…

1
252. CSIM Special Episode - Top Papers Runners Up Part 3 29:50

21d ago29:50

29:50

Send us a text In the final part of our series leading up to CSIM Dr. Mike Fralick of the Rounds Table sits down with Dr. Raj Hanmiah to discuss the papers that didn't make the cut for the top papers of the year. Join us as we record live at CSIM during the Top Papers breakfast session on October 17th for the reveal of the top 5 of the year! Suppor…

1
251. CSIM Special Episode- Internists can Help the Planet, Part 1 55:21

23d ago55:21

55:21

Send us a text There are everyday practices we can stop or reduce that don’t add value to patient care and harm the environment. In this special CSIM episode, host Dr. Zahra Merali sits down with guests Dr. Mathilde Gaudreau @MathildeGSimard (General Internist, University of Ottawa), Dr. Nabha Shetty (General Internist, Dalhousie University) and Dr…

1
250. A Little Too Sweet—The Internist’s Approach to Diabetes in Pregnancy 16:58

24d ago16:58

16:58

Send us a text In this episode, we review the screening, monitoring and treatment approaches to patients with diabetes in pregnancy. Our medicine minute reviews the MiTy trial - a landmark randomized controlled trial that provided direct safety data on the use of metformin in pregnancy. Written by: Dr. Ryan Peters (Internal Medicine Resident) Revie…

1
249. CSIM Special Episode - Top Papers Runners Up Part 2 25:19

28d ago25:19

25:19

Send us a text In part two of our series leading up to CSIM Dr. Zahra Merali sits down with Dr. Raj Hanmiah to discuss the papers that didn't make the cut for the top papers of the year. Keep tuning in to hear the rest and join us as we record live at CSIM during the Top Papers breakfast session on October 17th for the reveal of the top 5 of the ye…

1
ESMO 2024 Congress Highlights in Gynecologic Cancer: New Data Informing Treatment of Ovarian, Endometrial, and Cervical Cancers 30:45

30d ago30:45

30:45

In this episode, listen to Ana Oaknin, MD, PhD and Alexandra Leary, MD, PhD, share their clinical insights and takeaways on key updates and new data presented for ovarian, endometrial, and cervical cancer at the ESMO 2024 annual congress including: Phase III PRIMA/ENGOT-OV26/GOG-3012 Final OS Results: Niraparib as First-Line Maintenance in Advanced…

1
A Cancer Conversation: Optimizing the Care of Patients With CLL Through a Deeper Understanding of BTK Inhibitor Resistance 32:48

30d ago32:48

32:48

In this episode, listen to Matthew S. Davids, MD, MMSc, and Lindsey Roeker, MD, discuss BTK inhibitor resistance and how it shapes treatment choices for patients with CLL, including: Contemporary treatment paradigms for patients with CLL Safety and efficacy of current regimens Molecular testing, including when and how to test for BTK inhibitor res…

1
248. Unplugged - The Platelet Destroying Pathology of ITP 16:01

1M ago16:01

16:01

Send us a text In this episode, we discuss the epidemiology, clinical manifestations, investigations and treatment of ITP. Our medicine minute discusses the Harrington-Hollingsworth Experiment. Written by: Dr. Vanessa Giuliano (Internal Medicine Resident) Reviewed by: Drs. Taylor Dear and Zachary Liederman (Hematology) and Dr. Kevin Venus (General …

1
247. CSIM Special Episode - Top Papers Runners Up Part 1 27:13

1M ago27:13

27:13

Send us a text In the first of our series leading up to CSIM we sit down with Dr. Raj Hanmiah to discuss the papers that didn't make the cut for the top papers of the year. Keep tuning in to hear the rest and join us as we record live at CSIM during the Top Papers breakfast session on October 17th for the reveal of the top 5 of the year! Support th…

1
246. A Fungal Foe - An Approach to Invasive Aspergillosis 12:23

1M ago12:23

12:23

Send us a text In this episode, we discuss the history, epidemiology, clinical presentation, investigations and management for invasive aspergillosis. Written by: Dr. Ravinder Sandhu (Internal Medicine Resident) Reviewed by: Dr. Terrence Ho (Respirology) and Dr. John Neary (General Internal Medicine) Sound Editing by: Tony Walsh Support the show…

1
Episode 37: Supportive Oncology for Neuroendocrine Cancer 42:58

2M ago42:58

42:58

What is supportive care or supportive oncology? What is cancer-related distress? How might NET patients benefit from supportive care? Yale oncologist Dr. Maryam Lustberg suggests strategies to manage cancer-related fatigue, diarrhea, nausea, mouth sores, peripheral neuropathy, distress, anxiety, and anxiety. She also addresses considerations for fe…

1
A Leap of Faith? Elimination of Autologous Stem Cell Transplantation for Patients With Mantle Cell Lymphoma in First Remission 21:39

2M ago21:39

21:39

In this episode, Contributing Editor Tycel Phillips, MD, an associate professor of medicine and a hematologist-oncologist at City of Hope Medical Center in Duarte, California, talks with Martin Dreyling, MD, a professor of medicine and head of the lymphoma program at LMU Hospital in Munich. They discuss the TRIANGLE trial, conducted by Dr. Dreyling…

1
245. Medical Assistance in Dying: Supporting Our Patients from Living to Dying 16:28

2M ago16:28

16:28

Send us a text In this episode, we discuss the history, related legislation and procedures regarding Medical Assistance in Dying. This episode discusses the state of Medical Assistance in Dying in Canada in 2024. We encourage listeners to continue to be up-to-date on the local legislation and practices. Written by: Dr. Valerie Kim (Internal Medicin…

1
244. I@W X RoundsTable - Rare Diseases 26:23

2M ago26:23

26:23

Send us a text This week, Dr. Laiya Carayannopoulos from the Intern at Work Podcast and Dr. Mike Fralick from The Rounds Table, our new Medicine Pods collaboration, discuss two recent papers exploring the novel management of two rare diseases – ATTR Amyloidosis and Hereditary Angioedema. Two papers, here we go! Support the show…

1
243. Ask a Fellow- Medical & Surgical Management of The Hospitalized IBD Patient 26:16

2M ago26:16

26:16

Send us a text "Bad Gut Feeling" Medical & Surgical Management of The Hospitalized IBD Patient. This ask a fellow kicks off our first episode of the new academic year with one of our Queens site leads, Michael Scaffidi (Internal Medicine Resident) hosts Dr. Fiona Milne @not_shreks_wife (Gastroenterology fellow) and Dr. Daniel Potter (General Surger…

1
Introducing Medicine Pods! 6:07

2M ago6:07

6:07

Send us a text Welcome to Medicine Pods! Your one stop shop for everything internal medicine, prn. Find us at www.medicinepods.com to find everything from The Intern at Work, The Rounds Table, Everything You Need To Know and Trial Files all in one place. Support the showBy Medicine Pods

1
Available and Emerging Therapies for Progressive/Recurrent ROS1-Altered Advanced NSCLC 13:53

2M ago13:53

13:53

In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available and emerging clinical data for second-line and beyond treatments in patients with recurrent ROS1-altered advanced NSCLC including: Assessing ROS1-TKI resistance mutations with tumor and liquid biopsies in patients with ROS1-altered advan…

1
Available Clinical Data and Approved First-line Treatments for ROS1-Altered Advanced NSCLC 13:46

2M ago13:46

13:46

In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available clinical data in support of frontline treatments for ROS1-altered NSCLC including: Efficacy and safety data for crizotinib, entrectinib, and repotrectinib in patients with ROS1-altered advanced NSCLC Long-term safety observations for cri…

1
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer 17:15

2M ago17:15

17:15

Interview with Eileen M. O’Reilly, MD, author of Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer. Hosted by Vivek Subbiah, MD. Related Content: Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer

1
Anticoagulation Stewardship 25:56

2M ago25:56

25:56

In this episode, Contributing Editor Surbhi Shah, MD, a classical hematologist at Mayo Clinic in Phoenix, leads a conversation about anticoagulation stewardship. Her guests are Allison Burnett, PharmD, PhC, an antithrombosis stewardship pharmacist at the University of New Mexico Hospital and president of the Anticoagulation Forum, and Geoffrey Barn…

1
Identification of Immune Checkpoint Inhibitor–Induced Diabetes 14:36

2M ago14:36

14:36

Interview with Michelle Rengarajan, MD, PhD, author of Identification of Immune Checkpoint Inhibitor–Induced Diabetes. Hosted by Vivek Subbiah, MD. Related Content: Identification of Immune Checkpoint Inhibitor–Induced Diabetes

1
ROS1-Alterations and Molecular Testing in Advanced NSCLC 16:28

2M ago16:28

16:28

In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the current understanding of ROS1 rearrangements in non-small-cell lung cancer tumor biology and its implications for molecular testing and treatment selection including: ROS1-gene fusions in advanced lung cancer ROS1 testing recommendations with DNA …

1
Episode 36: "NEN Treatments: Focus on Immunotherapy" with Dr. Jennifer Eads 39:12

3M ago39:12

39:12

ABOUT THIS EPISODE What is immunotherapy? How effective are they for neuroendocrine neoplasms (NENs)? Dr. Jennifer Eads from Penn Medicine answers common questions about immunotherapy. She discusses the latest in CAR T therapy, DLL3, and vaccine therapy for NENs. TOP TEN QUESTIONS ABOUT IMMUNOTHERAPY FOR NENS: What is immunotherapy? How does it wor…

1
Midyear Highlights of Key Data From 2024 Gynecologic Cancer Conferences Informing Treatment of Ovarian, Endometrial, and Cervical Cancers 49:32

3M ago49:32

49:32

In this episode, listen to Floor J. Backes, MD, and Angeles Alvarez Secord, MD, MHSc, share their clinical insights and takeaways on new data presented for endometrial, ovarian, and cervical cancers presented at the 2024 annual meetings of the Society of Gynecologic Oncology and American Society of Clinical Oncology including: RUBY Part 1 Subgroup …

1
Wound Healing and Burn Care 31:49

4M ago31:49

31:49

This episode of Surgical Readings features an informative conversation led by Rick Greene, MD, FACS, with the associate editors for the Wound Healing and Burn Care issue. Laura Haines, MD, FACS, and Deepak Bharadia, MBBS, FACS, provide valuable perspectives on the management of non-healing wounds, prevention of hypertrophic scarring, and achieving …

1
EPISODE 35 - NEN Treatments: Focus on Chemotherapy 36:38

4M ago36:38

36:38

What is chemotherapy? When are they used for neuroendocrine neoplasms (NENs)? Dr. Pamela Kunz from Yale Medicine discusses the benefits, potential side effects and latest advances in chemotherapy for NENs. She explains how it differs from other treatments for NENs and how she counsels patients as they consider chemotherapy. TOP TEN QUESTIONS ABOUT …

1
Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs 34:45

3M ago34:45

34:45

In this episode, Dr Virginia Kaklamani moderates a discussion with Dr Aditya Bardia and Dr Sarah Sammons answering audience questions on the latest data on the use of oral SERDs therapy, including how to incorporate this new class of therapy into treatment plans for patients with HR+/HER2- breast cancer. Presenters: Virginia Kaklamani, MD, DSc Prof…

1
Current Clinical Practice and NCCN Guidelines for CLL/SLL 31:33

3M ago31:33

31:33

In this podcast episode, Farrukh Awan, MD, Jeremy S. Abramson, MD, MMSc, and Shuo Ma, MD, PhD, discuss real-world patient cases and how to align current clinical practice with the NCCN guidelines for CLL/SLL, including: Prognostic variables when deciding between regimens Role of MRD in CLL Results from the phase II CAPTIVATE trial Choosing among th…

1
Neoadjuvant Exercise Therapy in Prostate Cancer 19:01

4M ago19:01

19:01

Interview with Lee W. Jones, PhD, author of Neoadjuvant Exercise Therapy in Prostate Cancer: A Phase 1, Decentralized Nonrandomized Controlled Trial. Hosted by Vivek Subbiah, MD. Related Content: Neoadjuvant Exercise Therapy in Prostate Cancer

1
Blood Global Hematology Editor-in-Chief Shares Vision 16:52

4M ago16:52

16:52

In this episode, Editor-in-Chief Shaji Kumar, MD, a professor of medicine at Mayo Clinic in Rochester, Minnesota, talks with Jorge Cortes, MD, the inaugural editor-in-chief of Blood Global Hematology, one of the latest additions to the growing Blood journals portfolio. Dr. Cortes, director of the Georgia Cancer Center at Augusta University, shares …

1
Congress to Clinic: Expert Takeaways on Emerging Data for MPNs 28:35

4M ago28:35

28:35

In this episode, listen to Dr Brady L. Stein share his clinical insights and takeaways on new data for myeloproliferative neoplasms (MPNs) presented at the 2024 ASCO Annual Meeting and the EHA 2024 Congress including: Long-term survival adjusted for treatment crossover in patients with myelofibrosis (MF) treated with momelotinib vs danazol in the M…

1
CELMoDs: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways 24:23

4M ago24:23

24:23

In this podcast episode, Julio C. Chavez, MD, MS, and Alan Skarbnik, MD, discuss the emerging role of CELMoDs in NHL care, including: Rationale for targeting CELMoDs in NHL Mechanism of action of CELMoDs Key studies and available efficacy and safety data with investigational CELMoDs in NHL Key ongoing clinical trials of CELMoDs in NHL Strategies to…

1
Experts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer 24:30

4M ago24:30

24:30

In this episode, Dr Joyce O’Shaughnessy moderates a discussion with Dr Sara Hurvitz and Dr Erica Mayer answering audience questions on the latest data on incorporating CDK4/6 inhibitors into treatment plans for patients with HR+/HER2- breast cancer. Topics in this podcast include: Evidence from the monarchE and NATALEE trials of adjuvant abemacicli…

1
Congress to Clinic: Expert Takeaways on Emerging Data for AML 25:21

4M ago25:21

25:21

In this episode, listen to Professor Eunice S. Wang, MD, share her clinical insights and takeaways on new data for acute myeloid leukemia (AML) presented at the 2024 ASCO annual meeting and the EHA 2024 Congress including: Data from the prospective, single-center phase Ib/II study of FLAG-IDA plus venetoclax in newly diagnosed or relapsed/refractor…

1
Congress to Clinic: Expert Takeaways on Emerging Data for MDS 19:19

4M ago19:19

19:19

In this episode, listen to Professor Courtney DiNardo, MD, MSCE, share her clinical highlights and clinical takeaways on new data for myelodysplastic syndromes (MDS) presented at the 2024 ASCO annual meeting and the EHA 2024 Congress including: COMMANDS trial of luspatercept in transfusion-dependent, erythropoietin stimulating agent–naive, very low…

1
242. July Special - Personal Finances ft. The Loonie Doctor 49:06

4M ago49:06

49:06

Send us a text For this year's special episode, we sat down with Dr. Mark Soth of the Loonie Doctor and Money Scope to talk about approaching creating a healthy financial future for yourself as a resident and beyond. Support the showBy The Intern At Work

1
Endometrial Thickness as Diagnostic Triage for Endometrial Cancer in Black Individuals 15:04

4M ago15:04

15:04

Interview with Kemi M. Doll, MD, MSCR, author of Endometrial Thickness as Diagnostic Triage for Endometrial Cancer Among Black Individuals. Hosted by Vivek Subbiah, MD. Related Content: Endometrial Thickness as Diagnostic Triage for Endometrial Cancer Among Black Individuals

1
One on One With Dr. Fred Appelbaum 26:25

4M ago26:25

26:25

In this episode, Contributing Editor Lori Muffly, MD, MS, an associate professor of medicine specializing in blood and marrow transplantation and cellular therapy at Stanford University in California, talks with Fred Appelbaum, MD, executive vice president and deputy director at the Fred Hutchinson Cancer Center in Seattle, and a professor of medic…

1
Genetic Switch System Suggests Targeting of Mutant JAK2 Reverses Myeloproliferative Neoplasms 23:49

5M ago23:49

23:49

In this episode, Contributing Editor Bethan Psaila, MD, PhD, an associate professor of hematology at the University of Oxford’s MRC Weatherall Institute of Molecular Medicine, talks with Andrew Dunbar, MD, an assistant professor and independent lab investigator at MD Anderson Cancer Center in Houston, Texas. They discuss Dr. Dunbar’s paper recently…

1
241. A Total Eclipse of the Heart - An Approach to Cardiogenic Shock 14:24

5M ago14:24

14:24

Send us a text Written by: Dr. Vijay Gupta (Internal Medicine Resident) Reviewed by: Dr. Sabe De (Cardiologist) and Dr. Karen Geukers (General Internist) Support the showBy The Intern At Work

1
Episode 34: NET Treatments: Focus on PRRT 54:39

5M ago54:39

54:39

What is PRRT? How is it different from the more commonly used radiation treatment? What are the possible side effects? Dr. Riham El Khouli from the University of Kentucky in Lexington discusses common questions and concerns about PRRT and shares some of the latest advances. MEET DR. RIHAM EL KHOULI, MD, PHD Associate Professor of Radiology, UK Coll…

Podcasts Worth a Listen

Neoplasm Podcasts

Podcasts Worth a Listen

Quick Reference Guide